Simona M. Siboni

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome.

Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome.

Journal: American journal of hematology

Published: February 21, 2026

Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half-Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective Study.

Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half-Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective Study.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: July 28, 2025

Genetic determinants of clinical variability in type 2 von Willebrand disease: bridging genotype and phenotype.

Genetic determinants of clinical variability in type 2 von Willebrand disease: bridging genotype and phenotype.

Journal: Haematologica

Published: May 30, 2025

Platelet function abnormalities in acquired hemophilia A.

Platelet function abnormalities in acquired hemophilia A.

Journal: Research and practice in thrombosis and haemostasis

Published: May 21, 2025

Gynecologic and obstetric complications in women with congenital fibrinogen disorders: insights from the Prospective Rare Bleeding Disorders Database.

Gynecologic and obstetric complications in women with congenital fibrinogen disorders: insights from the Prospective Rare Bleeding Disorders Database.

Journal: Research and practice in thrombosis and haemostasis

Published: March 18, 2025

Management of Pregnancy, Delivery, and Postpartum in Italian Carriers and Women With Haemophilia A and B.

Management of Pregnancy, Delivery, and Postpartum in Italian Carriers and Women With Haemophilia A and B.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: January 13, 2025

Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review.

Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review.

Journal: Seminars in thrombosis and hemostasis

Published: June 27, 2024

Variant p.Tyr1584Cys: a frequent von Willebrand factor variant in search of von Willebrand disease.

Variant p.Tyr1584Cys: a frequent von Willebrand factor variant in search of von Willebrand disease.

Journal: Research and practice in thrombosis and haemostasis

Published: May 10, 2024

Factor VIII and von Willebrand factor are wavering proteins: the basis for the therapeutic development of desmopressin.

Factor VIII and von Willebrand factor are wavering proteins: the basis for the therapeutic development of desmopressin.

Journal: Research and practice in thrombosis and haemostasis

Published: February 27, 2024

Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A.

Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A.

Journal: Blood advances

Published: January 10, 2024

Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.

Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.

Journal: Blood advances

Published: November 15, 2023

Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWF.

Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWF.

Journal: Thrombosis and haemostasis

Published: October 06, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026